12:00 AM
 | 
Jul 27, 2009
 |  BC Week In Review  |  Company News  |  Deals

Archemix, Dicerna, miRagen deal

Archemix announced a pair of deals to use its aptamers to facilitate intracellular delivery of RNA-based therapeutics. Archemix and miRagen will develop conjugated...

Read the full 95 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >